Novo Nordisk's Wegovy weight loss drug launches in the UK
CNBC 2023-09-04 12:28:28 • 3 mins
Key Points
- Novo Nordisk launched its Wegovy weight loss injection in the U.K. on Monday, advancing the drug's rollout in Europe despite ongoing supply constraints.
- The Danish pharmaceutical giant said that the weekly injection would initially be available "through a controlled and limited launch."
- The drug will be available to certain patients through the U.K. National Health Service, as well as privately.
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy.
Stefan Trumpf | Picture Alliance | Getty Images
Novo Nordisk launched its Wegovy weight loss injection in the U.K. on Monday, advancing the drug's rollout in Europe despite ongoing supply constraints.
The Danish pharmaceutical giant said that the weekly injection would be available initially "through a controlled and limited launch," with only certain patients eligible to receive the drug on the country's National Health Service.
